233 related articles for article (PubMed ID: 26399324)
1. Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable, and hardware-independent optogenetic inhibition.
Tung JK; Gutekunst CA; Gross RE
Sci Rep; 2015 Sep; 5():14366. PubMed ID: 26399324
[TBL] [Abstract][Full Text] [Related]
2. Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.
Berglund K; Clissold K; Li HE; Wen L; Park SY; Gleixner J; Klein ME; Lu D; Barter JW; Rossi MA; Augustine GJ; Yin HH; Hochgeschwender U
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E358-67. PubMed ID: 26733686
[TBL] [Abstract][Full Text] [Related]
3. Step-function luminopsins for bimodal prolonged neuromodulation.
Berglund K; Fernandez AM; Gutekunst CN; Hochgeschwender U; Gross RE
J Neurosci Res; 2020 Mar; 98(3):422-436. PubMed ID: 30957296
[TBL] [Abstract][Full Text] [Related]
4. Combined Optogenetic and Chemogenetic Control of Neurons.
Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
[TBL] [Abstract][Full Text] [Related]
5. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin.
Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence-Optogenetics: A Practical Guide.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Berglund K; Gross RE
Methods Mol Biol; 2022; 2525():333-346. PubMed ID: 35836081
[TBL] [Abstract][Full Text] [Related]
7. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).
Prakash M; Medendorp WE; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529
[TBL] [Abstract][Full Text] [Related]
8. Novel luciferase-opsin combinations for improved luminopsins.
Park SY; Song SH; Palmateer B; Pal A; Petersen ED; Shall GP; Welchko RM; Ibata K; Miyawaki A; Augustine GJ; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):410-421. PubMed ID: 28862809
[TBL] [Abstract][Full Text] [Related]
9. Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity.
Zhang JY; Tung JK; Wang Z; Yu SP; Gross RE; Wei L; Berglund K
J Neurosci Res; 2020 Mar; 98(3):481-490. PubMed ID: 31670406
[TBL] [Abstract][Full Text] [Related]
10. Optogenetics: opsins and optical interfaces in neuroscience.
Adamantidis AR; Zhang F; de Lecea L; Deisseroth K
Cold Spring Harb Protoc; 2014 Aug; 2014(8):815-22. PubMed ID: 25086025
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive activation of optogenetic actuators.
Birkner E; Berglund K; Klein ME; Augustine GJ; Hochgeschwender U
Proc SPIE Int Soc Opt Eng; 2014 Feb; 8928():. PubMed ID: 27965518
[TBL] [Abstract][Full Text] [Related]
12. BiPOLES is an optogenetic tool developed for bidirectional dual-color control of neurons.
Vierock J; Rodriguez-Rozada S; Dieter A; Pieper F; Sims R; Tenedini F; Bergs ACF; Bendifallah I; Zhou F; Zeitzschel N; Ahlbeck J; Augustin S; Sauter K; Papagiakoumou E; Gottschalk A; Soba P; Emiliani V; Engel AK; Hegemann P; Wiegert JS
Nat Commun; 2021 Jul; 12(1):4527. PubMed ID: 34312384
[TBL] [Abstract][Full Text] [Related]
13. Light-emitting channelrhodopsins for combined optogenetic and chemical-genetic control of neurons.
Berglund K; Birkner E; Augustine GJ; Hochgeschwender U
PLoS One; 2013; 8(3):e59759. PubMed ID: 23544095
[TBL] [Abstract][Full Text] [Related]
14. Submillisecond Optogenetic Control of Neuronal Firing with Two-Photon Holographic Photoactivation of Chronos.
Ronzitti E; Conti R; Zampini V; Tanese D; Foust AJ; Klapoetke N; Boyden ES; Papagiakoumou E; Emiliani V
J Neurosci; 2017 Nov; 37(44):10679-10689. PubMed ID: 28972125
[TBL] [Abstract][Full Text] [Related]
15. Chemically activated luminopsins allow optogenetic inhibition of distributed nodes in an epileptic network for non-invasive and multi-site suppression of seizure activity.
Tung JK; Shiu FH; Ding K; Gross RE
Neurobiol Dis; 2018 Jan; 109(Pt A):1-10. PubMed ID: 28923596
[TBL] [Abstract][Full Text] [Related]
16. Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans.
Shen Y; Campbell RE; Côté DC; Paquet ME
Front Neural Circuits; 2020; 14():41. PubMed ID: 32760252
[TBL] [Abstract][Full Text] [Related]
17. Ancestral Adeno-Associated Virus Vector Delivery of Opsins to Spiral Ganglion Neurons: Implications for Optogenetic Cochlear Implants.
Duarte MJ; Kanumuri VV; Landegger LD; Tarabichi O; Sinha S; Meng X; Hight AE; Kozin ED; Stankovic KM; Brown MC; Lee DJ
Mol Ther; 2018 Aug; 26(8):1931-1939. PubMed ID: 30017876
[TBL] [Abstract][Full Text] [Related]
18. Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.
Yu C; Cassar IR; Sambangi J; Grill WM
J Neurosci; 2020 May; 40(22):4323-4334. PubMed ID: 32312888
[TBL] [Abstract][Full Text] [Related]
19. Monolithically Integrated μLEDs on Silicon Neural Probes for High-Resolution Optogenetic Studies in Behaving Animals.
Wu F; Stark E; Ku PC; Wise KD; Buzsáki G; Yoon E
Neuron; 2015 Dec; 88(6):1136-1148. PubMed ID: 26627311
[TBL] [Abstract][Full Text] [Related]
20. An efficient cell type specific conjugating method for incorporating various nanostructures to genetically encoded AviTag expressed optogenetic opsins.
Bang Y; Kim YY; Song YK
Biochem Biophys Res Commun; 2020 Sep; 530(3):581-587. PubMed ID: 32753317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
